CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Teva Pharmaceuticals USA, Inc. v. Sandoz Inc.

1:17-cv-00597

Overview

Case Number 1:17-cv-00597
Filing Date 2017-05-24
Status Terminated
Termination Date 2019-03-29
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Momenta Pharmaceuticals Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Sandoz Inc. Operating Company

Represented By

1 Attorneys Listed

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Plaintiff

Teva Neuroscience Inc Operating Company

Represented By

2 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Teva Pharmaceutical Industries Ltd Operating Company

Represented By

2 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Teva Pharmaceuticals U.S.A., Inc. Operating Company

Represented By

9 Attorneys Listed

Nicholas K. Mitrokostas

Email: nicholas.mitrokostas@allenovery.com

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Joshua S. Weinger

Email: jweinger@goodwinlaw.com

Jenny Zhang

Email: jzhang@goodwinlaw.com

Elizabeth J. Holland

Email: Elizabeth.Holland@allenovery.com

Daryl L. Wiesen

Email: dwiesen@goodwinlaw.com

Daniel P. Margolis

Email: dmargolis@goodwinlaw.com

Brian T. Drummond

Email: BDrummond@goodwinlaw.com

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 3 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (3 found):
U.S. Courts: 3
U.S. District Court 2017-04-07
1:17-cv-00390

Teva Pharmaceuticals USA, Inc. v. Synthon Pharmaceuticals, Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-02-02
1:17-cv-00109

Momenta Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-01-25
1:17-cv-00074

Amneal Pharmaceuticals LLC v. Teva Pharmaceuticals USA, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9155755
Dietary supplements including glucan and fulvic acid
Filed: 2014-03-12
Issued: 2015-10-13
Active (7.3 yrs remaining)
Expires: 2034-03-12

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

25

Dispositive

19

Granted

3

Denied

0

Pending / Review

19

Motions by Category

Motion to Transfer Venue (28 U.S.C. § 1404) 9 Motion to Dismiss 7 Procedural / Extension Motion 3 Motion for Preliminary Injunction / TRO 3 Claim Construction / Markman Filing 3

Key Dispositive Motions & Rulings

Motion to Transfer Venue (28 U.S.C. § 1404) Granted
ORDER granting 7 Motion to Transfer Case to United States District Court for the District of Delaware (USCA Electronically Notified). Signed by Judge Freda L. W...
Entry #90 • 2017-05-23 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
Letter from Sandoz Inc. re 7 MOTION to Transfer Case to United States District Court Delaware . (Attachments: # 1 Exhibit A)(SAVERIANO, CHRISTINA) [Transferred ...
Entry #76 • 2017-04-03 Document →
Motion to Dismiss Pending / Under Review
REPLY BRIEF to Opposition to Motion filed by MOMENTA PHARMACEUTICALS, INC., SANDOZ INC. re 58 MOTION to Dismiss (Attachments: # 1 Exhibit, # 2 Certificate of Se...
Entry #75 • 2017-03-30 Document →
Motion to Dismiss Pending / Under Review
MEMORANDUM in Opposition filed by TEVA NEUROSCIENCE, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. re 58 MOTION to Dismiss (Attachme...
Entry #71 • 2017-03-20 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
Letter from Liza M. Walsh to the Hon. Freda L. Wolfson, U.S.D.J. re: pending Motion for Preliminary Injunction (DE 51 and 52) (Filed Under Seal) re 52 Memorandu...
Entry #70 • 2017-03-17 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
Letter from Sandoz re 7 MOTION to Transfer Case to United States District Court Delaware . (Attachments: # 1 Exhibit A)(SAVERIANO, CHRISTINA) [Transferred from ...
Entry #68 • 2017-03-13 Document →

Docket Entries

(149 total)
Pleading / Complaint

COMPLAINT against MOMENTA PHARMACEUTICALS, INC., SANDOZ INC. ( Filing and Admin fee $400 receipt number 7589149), filed by TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA NEUROSCIENCE, INC.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jem) [Transferred from New Jersey on 5/24/2017.] (Entered: 01/17/2017)

Entry #1 • 2017-01-13
1

Corporate Disclosure Statement by TEVA NEUROSCIENCE, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. (jem) [Transferred from New Jersey on 5/24/2017.] (Entered: 01/17/2017)

Entry #2 • 2017-01-13
1

AO120 Patent Form filed. (jem) [Transferred from New Jersey on 5/24/2017.] (Entered: 01/17/2017)

Entry #3 • 2017-01-17
1

SUMMONS ISSUED as to MOMENTA PHARMACEUTICALS, INC., SANDOZ INC. Attached is the official court Summons, please fill out Defendant and Plaintiff's attorney information and serve. Issued By *John Moller* (jem) [Transferred from New Jersey on 5/24/2017.] (Entered: 01/17/2017)

Entry #4 • 2017-01-17
1

NOTICE of Appearance by ERIC I. ABRAHAM on behalf of All Defendants (ABRAHAM, ERIC) [Transferred from New Jersey on 5/24/2017.] (Entered: 01/26/2017)

Entry #5 • 2017-01-26
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc